These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24269474)

  • 1. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J
    Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398.
    Grammen C; Van den Mooter G; Appeltans B; Michiels J; Crucitti T; Ariën KK; Augustyns K; Augustijns P; Brouwers J
    Int J Pharm; 2014 Nov; 475(1-2):238-44. PubMed ID: 25175729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro profiling of the vaginal permeation potential of anti-HIV microbicides and the influence of formulation excipients.
    Grammen C; Augustijns P; Brouwers J
    Antiviral Res; 2012 Nov; 96(2):226-33. PubMed ID: 23000496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398.
    Ariën KK; Venkatraj M; Michiels J; Joossens J; Vereecken K; Van der Veken P; Heeres J; De Winter H; Heyndrickx L; Augustyns K; Vanham G
    J Antimicrob Chemother; 2016 May; 71(5):1159-68. PubMed ID: 26850721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission.
    Ariën KK; Venkatraj M; Michiels J; Joossens J; Vereecken K; Van der Veken P; Abdellati S; Cuylaerts V; Crucitti T; Heyndrickx L; Heeres J; Augustyns K; Lewi PJ; Vanham G
    J Antimicrob Chemother; 2013 Sep; 68(9):2038-47. PubMed ID: 23645585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of radiolabeled small molecule permeability as a quantitative measure of microbicide candidate toxicity.
    Coleman JS; Fuchs E; Aung WS; Marzinke MA; Bakshi RP; Spiegel HML; Robinson J; Hendrix CW
    Contraception; 2016 Apr; 93(4):331-336. PubMed ID: 26772905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.
    Yang J; Li L; Jin H; Tan S; Qiu J; Yang L; Ding Y; Jiang ZH; Jiang S; Liu S
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1498-508. PubMed ID: 22867271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention.
    Ham AS; Nugent ST; Peters JJ; Katz DF; Shelter CM; Dezzutti CS; Boczar AD; Buckheit KW; Buckheit RW
    Antiviral Res; 2015 Aug; 120():153-64. PubMed ID: 26093158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection.
    Ham AS; Ugaonkar SR; Shi L; Buckheit KW; Lakougna H; Nagaraja U; Gwozdz G; Goldman L; Kiser PF; Buckheit RW
    J Pharm Sci; 2012 Apr; 101(4):1423-35. PubMed ID: 22227864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.
    Garg S; Goldman D; Krumme M; Rohan LC; Smoot S; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S19-29. PubMed ID: 21109064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the Protein Microbicide 5P12-RANTES in Sheep following Single-Dose Vaginal Gel Administration.
    McBride JW; Dias N; Cameron D; Offord RE; Hartley O; Boyd P; Kett VL; Malcolm RK
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection.
    Brouwers J; Vermeire K; Schols D; Augustijns P
    Virology; 2008 Sep; 378(2):306-10. PubMed ID: 18606432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of anti-HIV microbicide products: New models and biomarkers.
    Doncel GF; Clark MR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S10-8. PubMed ID: 21109063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc.
    Forbes CJ; Lowry D; Geer L; Veazey RS; Shattock RJ; Klasse PJ; Mitchnick M; Goldman L; Doyle LA; Muldoon BC; Woolfson AD; Moore JP; Malcolm RK
    J Control Release; 2011 Dec; 156(2):161-9. PubMed ID: 21864598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission.
    Klasse PJ; Shattock R; Moore JP
    Annu Rev Med; 2008; 59():455-71. PubMed ID: 17892435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of supersaturation for the vaginal application of microbicides: a case study with dapivirine.
    Grammen C; Plum J; Van Den Brande J; Darville N; Augustyns K; Augustijns P; Brouwers J
    J Pharm Sci; 2014 Nov; 103(11):3696-3703. PubMed ID: 25231545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early identification of availability issues for poorly water-soluble microbicide candidates in biorelevant media: a case study with saquinavir.
    Brouwers J; Vermeire K; Grammen C; Schols D; Augustijns P
    Antiviral Res; 2011 Aug; 91(2):217-23. PubMed ID: 21683096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pilot Study Measuring the Distribution and Permeability of a Vaginal HIV Microbicide Gel Vehicle Using Magnetic Resonance Imaging, Single Photon Emission Computed Tomography/Computed Tomography, and a Radiolabeled Small Molecule.
    Fuchs EJ; Schwartz JL; Friend DR; Coleman JS; Hendrix CW
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1109-15. PubMed ID: 26077739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen.
    Geonnotti AR; Peters JJ; Katz DF
    J Pharm Sci; 2005 Aug; 94(8):1705-12. PubMed ID: 15986472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.